# FDA Inspection 1130375 - VRL Eurofins - August 26, 2020

Source: https://www.keypedia.com/records/fda_inspections/vrl-eurofins/ccfc18f9-3993-4be8-978e-7dde6750af7b
Source feed: FDA_Inspections

> FDA Inspection 1130375 for VRL Eurofins on August 26, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1130375
- Company Name: VRL Eurofins
- Inspection Date: 2020-08-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261192 - 2025-01-30](https://www.keypedia.com/records/fda_inspections/vrl-eurofins/897b9918-4213-439c-8ea8-95eecb72d18f)
- [FDA Inspection 1261192 - 2025-01-30](https://www.keypedia.com/records/fda_inspections/vrl-eurofins/d6eb9967-5e13-4ede-8ae6-9906d1397f54)
- [FDA Inspection 1130375 - 2020-08-26](https://www.keypedia.com/records/fda_inspections/vrl-eurofins/bf84bd9e-510c-4655-951a-ea6a92fb9ec4)
- [FDA Inspection 1027461 - 2017-09-14](https://www.keypedia.com/records/fda_inspections/vrl-eurofins/d88648ed-6ad2-4086-b06d-e8506962565c)
- [FDA Inspection 901718 - 2014-10-29](https://www.keypedia.com/records/fda_inspections/vrl-eurofins/df00af64-ef74-466d-a350-c3c328eeb075)

Company: https://www.keypedia.com/companies/vrl-eurofins/50158b01-810a-402a-8a30-e8b7021b8b3f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d